Cummings: EpiPen CEO raised prices to get ‘filthy rich’

Published



House leaders on Wednesday blasted the CEO of EpiPen’s manufacturer, which raised the price of the allergy drug by 400 percent, saying that the sharp price increase could endanger the lives of their constituents.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.